标普和纳斯达克内在价值 联系我们

Genomma Lab Internacional, S.A.B. de C.V. GNMLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • MX • USD

SharesGrow Score
80/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) 是一家上市公司 属于 医疗保健 板块,经营于 制药 - 专科与仿制药 行业. 公司总部位于 Mexico City, DF, 墨西哥. 现任CEO为 Juan Marco Sparvieri.

GNMLF 拥有 IPO日期为 2012-05-04, 1,605 名全职员工, 在 Other OTC, 市值为 $1.05B.

关于 Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

📍 Av. Antonio Dovalí Jaime no.70, Mexico City, DF 01210 📞 52 55 5081 0000
公司详情
所属板块医疗保健
细分行业制药 - 专科与仿制药
国家墨西哥
交易所Other OTC
货币USD
IPO日期2012-05-04
首席执行官Juan Marco Sparvieri
员工数1,605
交易信息
当前价格$1.08
市值$1.05B
52周区间0.91-1.43
Beta0.55
ETF
ADR
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言